Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MUPIROCIN 2% CREAM

Mupirocin
$0.8245per GM

Strength

2 g/100g

Manufacturer

Encube Ethicals, Inc.

NDC

21922002905

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

MUPIROCIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA213076

On Market Since

9/2/2021

Pharmacological Classes

RNA Synthetase Inhibitor Antibacterial
RNA Synthetase Inhibitors

Price History

1W

0.0%

1M

-1.4%

3M

-13.5%

6M

+7.9%

1Y

-0.2%

3Y

-28.1%

5Y

N/A

All

-88.8%

Generic Alternatives

3 alternatives • Same active ingredient

MUPIROCIN 2% CREAM
Generic
69238202903•Amneal Pharmaceuticals NY LLC
$0.8245
MUPIROCIN 2% CREAM
Generic
68462056435•Glenmark Pharmaceuticals Inc., USA
$0.8245
MUPIROCIN 2% CREAM
Generic
21922002904•Encube Ethicals, Inc.
$1.0213
+24% more

Related Drugs

Same classification

MUPIROCIN 2% OINTMENT
Generic
21922007325•Encube Ethicals, Inc.
$0.1330
per GM
MUPIROCIN 2% OINTMENT
Generic
21922007304•Encube Ethicals, Inc.
$0.2847
per GM
MUPIROCIN 2% CREAM
Generic
16714005502•NorthStar Rx LLC
$0.8245
per GM
MUPIROCIN 2% CREAM
Generic
51672137002•Sun Pharmaceutical Industries Inc.
$0.8245
per GM
MUPIROCIN 2% CREAM
Generic
62332062430•Alembic Pharmaceuticals Inc.
$0.8245
per GM
MUPIROCIN 2% CREAM
Generic
16714005501•NorthStar Rx LLC
$1.0213
per GM
MUPIROCIN 2% CREAM
Generic
51672137001•Sun Pharmaceutical Industries Inc.
$1.0213
per GM
MUPIROCIN 2% CREAM
Generic
62332062415•Alembic Pharmaceuticals Inc.
$1.0213
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy